Sleep disturbance, distress, and quality of life in ovarian cancer patients during the first year after diagnosis

Lauren Clevenger, Andrew Schrepf, Koenraad De Geest, David Bender, Michael Goodheart, Amina Ahmed, Laila Dahmoush, Frank Penedo, Joseph Lucci, Premal H. Thaker, Luis Mendez, Anil K. Sood, George M. Slavich, Susan K. Lutgendorf

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Background Sleep disturbance is a common clinical complaint of oncology patients and contributes to substantial morbidity. However, because most sleep studies have been cross-sectional, associations between sleep quality and distress in patients with ovarian cancer over time remain unclear. This prospective longitudinal study examined rates of sleep disturbance; contributions of depression, anxiety, and medication use in sleep disturbance; and associations between sleep quality and quality of life (QOL) during the first year after diagnosis among women with ovarian cancer. Methods Women with a pelvic mass completed measures of sleep quality, depression, anxiety, and QOL before surgery. Those diagnosed with primary epithelial ovarian, fallopian tube, or peritoneal cancer repeated surveys at 6 months and 1 year after diagnosis. Mixed modeling was used to examine trajectories of psychosocial measures over time, as well as associations between changes in distress and sleep quality. Relationships between changes in sleep and QOL were also examined. Results The majority of patients reported disturbed global sleep (Pittsburgh Sleep Quality Index > 5) at all 3 time points. Medications for sleep and pain were associated with worse sleep at all time points. Greater increases in depression were associated with increased disturbances in sleep quality over time (P

Original languageEnglish (US)
Pages (from-to)3234-3241
Number of pages8
JournalCancer
Volume119
Issue number17
DOIs
StatePublished - Sep 1 2013
Externally publishedYes

Fingerprint

Ovarian Neoplasms
Sleep
Quality of Life
Depression
Anxiety
Medical Oncology
Fallopian Tubes
Longitudinal Studies
Prospective Studies
Morbidity

Keywords

  • anxiety
  • depression
  • insomnia
  • ovarian cancer
  • quality of life

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Clevenger, L., Schrepf, A., De Geest, K., Bender, D., Goodheart, M., Ahmed, A., ... Lutgendorf, S. K. (2013). Sleep disturbance, distress, and quality of life in ovarian cancer patients during the first year after diagnosis. Cancer, 119(17), 3234-3241. https://doi.org/10.1002/cncr.28188

Sleep disturbance, distress, and quality of life in ovarian cancer patients during the first year after diagnosis. / Clevenger, Lauren; Schrepf, Andrew; De Geest, Koenraad; Bender, David; Goodheart, Michael; Ahmed, Amina; Dahmoush, Laila; Penedo, Frank; Lucci, Joseph; Thaker, Premal H.; Mendez, Luis; Sood, Anil K.; Slavich, George M.; Lutgendorf, Susan K.

In: Cancer, Vol. 119, No. 17, 01.09.2013, p. 3234-3241.

Research output: Contribution to journalArticle

Clevenger, L, Schrepf, A, De Geest, K, Bender, D, Goodheart, M, Ahmed, A, Dahmoush, L, Penedo, F, Lucci, J, Thaker, PH, Mendez, L, Sood, AK, Slavich, GM & Lutgendorf, SK 2013, 'Sleep disturbance, distress, and quality of life in ovarian cancer patients during the first year after diagnosis', Cancer, vol. 119, no. 17, pp. 3234-3241. https://doi.org/10.1002/cncr.28188
Clevenger, Lauren ; Schrepf, Andrew ; De Geest, Koenraad ; Bender, David ; Goodheart, Michael ; Ahmed, Amina ; Dahmoush, Laila ; Penedo, Frank ; Lucci, Joseph ; Thaker, Premal H. ; Mendez, Luis ; Sood, Anil K. ; Slavich, George M. ; Lutgendorf, Susan K. / Sleep disturbance, distress, and quality of life in ovarian cancer patients during the first year after diagnosis. In: Cancer. 2013 ; Vol. 119, No. 17. pp. 3234-3241.
@article{a5cd6fce04e34d578520a9951b9fb21d,
title = "Sleep disturbance, distress, and quality of life in ovarian cancer patients during the first year after diagnosis",
abstract = "Background Sleep disturbance is a common clinical complaint of oncology patients and contributes to substantial morbidity. However, because most sleep studies have been cross-sectional, associations between sleep quality and distress in patients with ovarian cancer over time remain unclear. This prospective longitudinal study examined rates of sleep disturbance; contributions of depression, anxiety, and medication use in sleep disturbance; and associations between sleep quality and quality of life (QOL) during the first year after diagnosis among women with ovarian cancer. Methods Women with a pelvic mass completed measures of sleep quality, depression, anxiety, and QOL before surgery. Those diagnosed with primary epithelial ovarian, fallopian tube, or peritoneal cancer repeated surveys at 6 months and 1 year after diagnosis. Mixed modeling was used to examine trajectories of psychosocial measures over time, as well as associations between changes in distress and sleep quality. Relationships between changes in sleep and QOL were also examined. Results The majority of patients reported disturbed global sleep (Pittsburgh Sleep Quality Index > 5) at all 3 time points. Medications for sleep and pain were associated with worse sleep at all time points. Greater increases in depression were associated with increased disturbances in sleep quality over time (P",
keywords = "anxiety, depression, insomnia, ovarian cancer, quality of life",
author = "Lauren Clevenger and Andrew Schrepf and {De Geest}, Koenraad and David Bender and Michael Goodheart and Amina Ahmed and Laila Dahmoush and Frank Penedo and Joseph Lucci and Thaker, {Premal H.} and Luis Mendez and Sood, {Anil K.} and Slavich, {George M.} and Lutgendorf, {Susan K.}",
year = "2013",
month = "9",
day = "1",
doi = "10.1002/cncr.28188",
language = "English (US)",
volume = "119",
pages = "3234--3241",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "17",

}

TY - JOUR

T1 - Sleep disturbance, distress, and quality of life in ovarian cancer patients during the first year after diagnosis

AU - Clevenger, Lauren

AU - Schrepf, Andrew

AU - De Geest, Koenraad

AU - Bender, David

AU - Goodheart, Michael

AU - Ahmed, Amina

AU - Dahmoush, Laila

AU - Penedo, Frank

AU - Lucci, Joseph

AU - Thaker, Premal H.

AU - Mendez, Luis

AU - Sood, Anil K.

AU - Slavich, George M.

AU - Lutgendorf, Susan K.

PY - 2013/9/1

Y1 - 2013/9/1

N2 - Background Sleep disturbance is a common clinical complaint of oncology patients and contributes to substantial morbidity. However, because most sleep studies have been cross-sectional, associations between sleep quality and distress in patients with ovarian cancer over time remain unclear. This prospective longitudinal study examined rates of sleep disturbance; contributions of depression, anxiety, and medication use in sleep disturbance; and associations between sleep quality and quality of life (QOL) during the first year after diagnosis among women with ovarian cancer. Methods Women with a pelvic mass completed measures of sleep quality, depression, anxiety, and QOL before surgery. Those diagnosed with primary epithelial ovarian, fallopian tube, or peritoneal cancer repeated surveys at 6 months and 1 year after diagnosis. Mixed modeling was used to examine trajectories of psychosocial measures over time, as well as associations between changes in distress and sleep quality. Relationships between changes in sleep and QOL were also examined. Results The majority of patients reported disturbed global sleep (Pittsburgh Sleep Quality Index > 5) at all 3 time points. Medications for sleep and pain were associated with worse sleep at all time points. Greater increases in depression were associated with increased disturbances in sleep quality over time (P

AB - Background Sleep disturbance is a common clinical complaint of oncology patients and contributes to substantial morbidity. However, because most sleep studies have been cross-sectional, associations between sleep quality and distress in patients with ovarian cancer over time remain unclear. This prospective longitudinal study examined rates of sleep disturbance; contributions of depression, anxiety, and medication use in sleep disturbance; and associations between sleep quality and quality of life (QOL) during the first year after diagnosis among women with ovarian cancer. Methods Women with a pelvic mass completed measures of sleep quality, depression, anxiety, and QOL before surgery. Those diagnosed with primary epithelial ovarian, fallopian tube, or peritoneal cancer repeated surveys at 6 months and 1 year after diagnosis. Mixed modeling was used to examine trajectories of psychosocial measures over time, as well as associations between changes in distress and sleep quality. Relationships between changes in sleep and QOL were also examined. Results The majority of patients reported disturbed global sleep (Pittsburgh Sleep Quality Index > 5) at all 3 time points. Medications for sleep and pain were associated with worse sleep at all time points. Greater increases in depression were associated with increased disturbances in sleep quality over time (P

KW - anxiety

KW - depression

KW - insomnia

KW - ovarian cancer

KW - quality of life

UR - http://www.scopus.com/inward/record.url?scp=84882698171&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84882698171&partnerID=8YFLogxK

U2 - 10.1002/cncr.28188

DO - 10.1002/cncr.28188

M3 - Article

C2 - 23797955

AN - SCOPUS:84882698171

VL - 119

SP - 3234

EP - 3241

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 17

ER -